Positive association of the AMPA receptor subunit GluR4 gene (GRIA4) haplotype with schizophrenia: Linkage disequilibrium mapping using SNPs evenly distributed across the gene region

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 116 B, Issue 1, 2003, Pages 17-22

  Makino, Chieko ^a   Fujii, Yo ^a   Kikuta, Rumiko ^a   Hirata, Naotsugu ^a   Tani, Ayako ^a   Shibata, Atsushi ^a   Ninomiya, Hideaki ^b   Tashiro, Nobutada ^c   Shibata, Hiroki ^a   Fukumaki, Yasuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Fukuoka Prefectural Dazaifu Hospital   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

GRIA4; Haplotype association study; Linkage disequilibrium; Schizophrenia; SNP marker

Indexed keywords

AMPA RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 4; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0042178301     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.10041     Document Type: Article

References (24)

1. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA. 2000. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry 157:1141-1149.
2. Goddard KA, Hopkins PJ, Hall JM, Witte JS. 2000. Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymorphisms in five populations. Am J Hum Genet 66:216-234.
3. Healy DJ, Meador-Woodruff JH. 1996. Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems. Brain Res 708:38-44.
4. Healy DJ, Meador-Woodruff JH. 1997. Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum. Brain Res Mol Brain Res 47:331-338.
5. Hollmann M, Heinemann S. 1994. Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
6. Ibrahim HM, Hogg AJ Jr, Healy DJ, Haroutunian V, Davis KL, Meador-Woodruff JH. 2000. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am J Psychiatry 157:1811-1823.
7. Javitt DC, Zukin SR. 1991. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
8. Jeffreys AJ, Kauppi L, Neumann R. 2001. Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. Nat Genet 29:217-222.
9. Joo A, Shibata H, Ninomiya H, Kawasaki H, Tashiro N, Fukumaki Y. 2001. Structure and polymorphisms of the human metabotropic glutamate receptor type 2 gene (GRM2): analysis of association with schizophrenia. Mol Psychiatry 6:186-192.
10. Kruglyak L. 1999. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 22:139-144.
11. Lahiri DK, Nurnberger JI Jr. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
12. Lewontin RC. 1988. On measures of gametic disequilibrium. Genetics 120:849-852.
13. Lewontin RC. 1995. The detection of linkage disequilibrium in molecular sequence data. Genetics 140:377-388.
14. Luby ED, Cohen BD, Rosenbaum G, Gottilieb JS, Kelley R. 1959. Study of a new schizophrenomimetic drug-sernyl. Am Med Assoc Arch Nerol Psychiatry 81:363-369.
15. McInnis MG, Swift-Scanlanl T, Mahoney AT, Vincent J, Verheyen G, Lan TH, Oruc L, Riess O, Broeckhoven CV, Chen H, Kennedy JL, MacKinnon DF, Margolis RL, Simpson SG, McMahon FJ, Gershon E, Nurnberger J, Reich T, DePaulo JR, Ross CA. 2000. Allelic distribution of CTG18.1 in Caucasian populations: association studies in bipolar disorder, schizophrenia, and ataxia. Mol Psychiatry 5:439-442.
16. Meador-Woodruff JH, Healy DJ. 2000. Glutamate receptor expression in schizophrenic brain. Brain Res Brain Res Rev 31:288-294.
17. Moghaddam B, Adams BW. 1998. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281: 1349-1352.
18. Moghaddam B, Adams B, Verma A, Daly D. 1997. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927.
19. Noga JT, Hyde TM, Bachus SE, Herman MM, Kleinman JE. 2001. AMPA receptor binding in the dorsolateral prefrontal cortex of schizophrenics and controls. Schizophr Res 48:361-363.
20. Ohashi J, Yamamoto S, Tsuchiya N, Hatta Y, Komata T, Matsushita M, Tokunaga K. 2001. Comparison of statistical power between 2 x 2 allele frequency and positivity tables in case-control studies of complex disease genes. Ann Hum Genet 65:197-206.
21. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, Lavery T, Kouyoumjian R, Farhadian SF, Ward R, Lander ES. 2001. Linkage disequilibrium in the human genome. Nature 411:199-204.
22. Schneider S, Roessli D, Excoffier L. 2000. Arlequin: a software for population genetics data analysis. Ver 2.000. Geneva: Genetics and Biometry Lab, Dept. of Anthropology, University of Geneva.
23. Shibata H, Joo A, Fujii Y, Tani A, Makino C, Hirata N, Kikuta R, Ninomiya H, Tashiro N, Fukumaki Y. 2001. Association study of polymorphisms in the GluR5 kainate receptor gene (GRIK1) with schizophrenia. Psychiatr Genet 11:139-144.
24. Terwilliger J, Ott J. 1994. Handbook of human genetic linkage. Baltimore: John Hopkins University Press.